Abstract: Provided are a recombinant microorganisms having a genetic modification that increases the expression of bacterioferritin, a composition comprising the recombinant microorganism for use in reducing a nitrogen oxide concentration in a sample, and a method of reducing a nitrogen oxide concentration in a sample.

Abstract: The present invention relates to a device and a method for measuring skin changes caused by blue light. A device for measuring skin changes caused by blue light according to one embodiment of the present invention comprises: at least one light source for irradiating light of a blue light band at different light amounts to a plurality of test areas set on a skin area to be tested; and a control unit for detecting a minimum pigmentation point among the test areas and calculating a light amount of the corresponding test area as a minimum pigmentation dose (MPD) for blue light. In addition, the present invention relates to a blue light irradiation device for irradiating a plurality of blue light beams in order to measure skin changes caused by blue light.

Abstract: Provided is a binder for a secondary battery including a copolymer including repeating units of the Chemical Formula 1, Chemical Formula 2, Chemical Formula 3, and Chemical Formula 4 disclosed herein. When the binder for a secondary battery is applied to a negative electrode and a secondary battery, expansion of the negative electrode may be effectively suppressed. Furthermore, the binder for a secondary battery has improved adhesion to effectively suppress exfoliation and desorption of a negative electrode, thereby manufacturing a secondary battery having significantly improved charge/discharge cycle characteristics and battery performance by using the binder.

Abstract: A computing device includes at least one memory, and at least one processor configured to generate, based on first analysis on a pathological slide image, first biomarker expression information, generate, based on a user input for updating at least some of results of the first analysis, second biomarker expression information about the pathological slide image, and control a display device to output a report including medical information about at least some regions included in the pathological slide image, based on at least one of the first biomarker expression information or the second biomarker expression information.

Abstract: A display is provided. The display device includes a display area and a non-display area located around the display area; a base layer; an organic light-emitting diode (OLED) that is located on the base layer in the display area; and a first crack detection line that is located on the base layer in the non-display area; wherein the first crack detection line comprises a first line that extends substantially in a first direction along a first edge of the display area, a second line that is separated from the first line and extends substantially in the first direction, and a third line that is connected to an end of the first line and an end of the second line, wherein a cross-sectional shape of the first line in a second direction crossing the first direction is inversely tapered.

Abstract: The present disclosure relates to a plurality of host materials, organic electroluminescent compounds, and organic electroluminescent devices comprising the same. By comprising specific combinations of compounds according to the present disclosure as the plurality of host materials or by comprising a compound according to the present disclosure, it is possible to provide organic electroluminescent devices having improved lifespan characteristics compared to conventional organic electroluminescent devices.

Abstract: A battery diagnosing apparatus includes a measuring unit configured to measure voltage and temperature of a battery, an ohmic resistance determining unit configured to determine an ohmic resistance of the battery based on an impedance profile generated for the battery, and a control unit configured to calculate a voltage change amount by comparing the voltage of the battery measured by the measuring unit with a reference voltage, calculate a resistance change rate by comparing the ohmic resistance determined by the ohmic resistance determining unit with a reference resistance, judge an internal gas generation level of the battery by comparing magnitudes of the calculated resistance change rate and a criterion resistance change rate, and judge an internal gas generation cause of the battery by comparing magnitudes of the calculated voltage change amount and a criterion voltage change amount.

Abstract: A semiconductor device is provided. The semiconductor device includes a first stacked structure including a plurality of first insulating patterns and a plurality of first semiconductor patterns alternately stacked on a substrate, the first stacked structure extending in a first direction parallel to an upper surface of the substrate, a first conductive pattern on one side surface of the first stacked structure, the first conductive pattern extending in a second direction crossing the upper surface of the substrate, and a first ferroelectric layer between the first stacked structure and the first conductive pattern, the first ferroelectric layer extending in the second direction, wherein each of the first semiconductor patterns includes a first impurity region, a first channel region and a second impurity region which are sequentially arranged along the first direction.

Abstract: A hydrogen storage system is disclosed and includes a storage unit including a plurality of unit storage containers, in which metal hydride materials are respectively provided in an interior thereof and which are connected to each other in parallel, and a thermal fluid line defining a thermal fluid passage, which passes via the plurality of unit storage containers continuously and through which a thermal fluid flows for heating or cooling the unit storage containers, thereby enhancing a storage performance and an efficiency of the hydrogen.

Abstract: Disclosed are an artificial intelligence device and a method for operating the same. An artificial intelligence device according to at least one embodiment of various embodiments of the present disclosure includes: a display; and a processor configured to control the display, wherein the processor is configured to: receive and register a first wake-up word; activate a voice recognition function when the registered first wake-up word is received, and transmit the first wake-up word to a server, wherein the first wake-up word is not a basic wake-up word embedded in the artificial intelligence device.

Abstract: A hydrogen storage device includes a storage container having an accommodation space in an interior thereof, a first metal hydride material provided in the interior of the storage container and that stores hydrogen, and a second metal hydride material provided in the interior of the storage container and that stores the hydrogen at a pressure that is different from that of the first metal hydride material. An advantageous effect of restraining an excessive rise of a pressure of the storage container and enhancing safety and reliability may be obtained.

Abstract: The present disclosure relates to an anti-pinch control system. The anti-pinch control system includes a motor configured to generate driving force for moving a seat of a vehicle, a current measurement sensor configured to measure a value of the current generated by the motor, a database unit configured to store the values of current measured by the current measurement sensor, and a controller configured to vary an anti-pinch value of the seat based on an average of a plurality of values of current measured every preset measurement period for a predetermined time, stored in the database unit, wherein the plurality of values of current is values of current measured before the predetermined time based on a current time.

Abstract: The present invention relates to an epitope of a thioredoxin-1 (Trx1) antigen and a use thereof, and more particularly, to the epitope, and an antibody or an antigen-binding fragment binding thereto. The epitope region of the human Trx1 antigen confirmed in the present invention may be effectively used in the development of an improved antibody to enhance the binding affinity of an anti-Trx1 antibody. In addition, the improved antibody of the present invention is effective in improvement of performance of a breast cancer diagnosis kit due to excellent binding affinity for Trx1 and very high sensitivity and specificity, compared to a conventional anti-Trx1 antibody. Further, the accuracy and reliability of breast cancer diagnosis may significantly increase because exceptionally high sensitivity and specificity are exhibited by detecting the monoclonal antibody of the present invention, which specifically binds to Trx1, rather than detecting CA15-3, another conventional breast cancer diagnostic biomarker.

Abstract: The present invention relates to a novel compound exhibiting anti-inflammatory activity, and the compound of the present invention plays a key role in the generation of pro-inflammatory cytokines, thereby having excellent inhibitory activity against p38 MAPK, which is known to cause inflammatory diseases, and thus can be effectively used as an agent for treating inflammatory diseases.

Abstract: An example electronic device includes a display, a communication circuit, a memory, and at least one processor configured to, based on a signal for requesting transmission of identification information including a call word for using first mode of an artificial intelligence assistant function of the electronic device being received, from another electronic device, through the communication circuit using first communication method, control the display to display a user interface for requesting user confirmation for transmission of the identification information; control the communication circuit to transmit the identification information to the another electronic device as a result of user confirmation through the user interface; and receive information for using a second communication method from the another electronic device.

Abstract: An aerosol generating article includes: a first segment impregnated with a first liquid composition; a second segment impregnated with a second liquid composition that is different from the first liquid composition; a cooler configured to cool aerosol by allowing the aerosol, generated from the first segment or the second segment, to pass through the cooler; and a filter configured to filter the aerosol by allowing the aerosol having passed through the cooler to pass through the filter, wherein at least a portion of the filter is recessed to thereby form a cavity in the filter.

Abstract: Disclosed is non-woven fabric for a vehicle internal material, a manufacturing method of the non-woven fabric, and a cargo screen for a vehicle using the non-woven fabric for a vehicle internal material, wherein the manufacturing method of non-woven fabric for a vehicle internal material is configured to includes forming a felt by mixing LM PET (Low melting polyethylene terephthalate) staple fibers having a melting point in the range of 120 to 140° C. and 150 to 170° C. and PET staple fibers; and thermo-compression molding the felt.

Abstract: A method of reducing a concentration of a nitrogen oxide, the method comprising: contacting a microorganism with a nitrogen oxide-containing sample to reduce the concentration of the nitrogen oxide in the sample, wherein the contacting comprises contacting the microorganism with Fe(II)(L)-NOx in a bioreactor, wherein the Fe(II)(L)-NOx is a complex in which a chelating agent, Fe2+, and NOx are chelated, wherein L is the chelating agent, and wherein NOx is a nitrogen oxide ligand.

Abstract: Disclosed is an apparatus and method for controlling an operation of a secondary battery using a relative deterioration degree of an electrode. The method includes determining a SOC of the secondary battery whenever a pulse current flows through the secondary battery; determining an electrochemical reaction resistance from a voltage change amount measured during a preset initial time in each pulse current section and determining a lithium ion diffusion resistance from a voltage change amount measured during a remaining time except for the initial time; determining a deterioration-biased electrode by comparing a deterioration diagnosing resistance ratio, which is a relative ratio of the lithium ion diffusion resistance to the electrochemical reaction resistance, with a preset reference deterioration diagnosing resistance ratio; and adaptively adjusting an operation condition of a next charging/discharging cycle according to the type of the deterioration-biased electrode.

Abstract: The present invention relates to a composition, for prevention or treatment of cancer diseases, comprising CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as an active ingredient. It was found that the secretion of extracellular vesicles from cytokine-activated CD4+ T cells increases and the extracellular vesicles enhance proliferation and activity of CD8+ T cells to induce the death of cancer cells, thereby augmenting an anticancer effect. Thus, the present invention provides the CD8+ T cells activated by CD4+ T cell-derived extracellular vesicles as a pharmaceutical agent or an immunotherapeutic agent for cancer diseases, and a method for activating CD8+ T cells by using CD4+ T cell-derived extracellular vesicles to prepare CD8+ T cells showing excellent anticancer activity as described above.